DoMore Diagnostics announces that Sophie Grindstad and Ole J. Dahlberg join as new members to the Board of Directors

DoMore Diagnostics announces that Sophie Grindstad and Ole J. Dahlberg have been elected as new members to the Board of Directors. Sophie Grindstad is an experienced growth strategist and advisor with former experience in management consulting. She is a Partner at Norselab and will replace Ivar Kroghrud. Chairman of the Board Tomas Alme says:

“We warmly welcome Sophie to the board and her support to the team. We also would like to express our gratitude for Ivar’s contributions to the company.”


Ole J. Dahlberg brings 25 years of experience from the life science industry. In addition to having co-founded three start-up companies, Dahlberg has worked both on the commercial side, and in R&D leadership roles. Chairman of the Board, Dr. Tomas Alme says:

“We are very pleased to have attracted a seasoned executive like Mr. Dahlberg to our Board of Directors. Mr. Dahlberg has an impressive track record in life sciences and brings international experience and knowledge to the company. His background in both R&D and commercial roles in the industry will be important additions to the company.”


Previous
Previous

DoMore Diagnostics congratulates Prof. Håvard Danielsen with the King Olav V´s Cancer Research Prize for 2022

Next
Next

DoMore Diagnostics announces the formation of our Scientific Advisory Board